Table of Contents
• Nasopharyngeal Cancer overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Nasopharyngeal Cancer Market
• Global Epidemiology of Nasopharyngeal Cancer Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Nasopharyngeal Cancer Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Nasopharyngeal Cancer (2013-2023)
• Table 7: Nasopharyngeal Cancer Global Market (USD Millions), (2013-2015)
• Table 8: Nasopharyngeal Cancer Global Market (USD Millions), (2016-2023)
• Table 9: Nasopharyngeal Cancer US Market (USD Millions), (2013-2015)
• Table 10: Nasopharyngeal Cancer US Market (USD Millions), (2016-2023)
• Table 11: Nasopharyngeal Cancer Germany Market (USD Millions), (2013-2015)
• Table 12: Nasopharyngeal Cancer Germany Market (USD Millions), (2016-2023)
• Table 13: Nasopharyngeal Cancer United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Nasopharyngeal Cancer United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Nasopharyngeal Cancer France Market (USD Millions), (2013-2015)
• Table 16: Nasopharyngeal Cancer France Market (USD Millions), (2016-2023)
• Table 17: Nasopharyngeal Cancer Italy Market (USD Millions), (2013-2015)
• Table 18: Nasopharyngeal Cancer Italy Market (USD Millions), (2016-2023)
• Table 19: Nasopharyngeal Cancer Spain Market (USD Millions), (2013-2015)
• Table 20: Nasopharyngeal Cancer Spain Market (USD Millions), (2016-2023)
• Table 21: Nasopharyngeal Cancer Japan Market (USD Millions), (2013-2015)
• Table 22: Nasopharyngeal Cancer Japan Market (USD Millions), (2016-2023)
• Table 23: Nasopharyngeal Cancer ROW Market (USD Millions), (2013-2015)
• Table 24: Nasopharyngeal Cancer ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Nasopharyngeal Cancer Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Nasopharyngeal Cancer (2013-2023)
• Figure 3: Nasopharyngeal Cancer Global Market (USD Millions), (2013-2015)
• Figure 4: Nasopharyngeal Cancer Global Market (USD Millions), (2016-2023)
• Figure 5: Nasopharyngeal Cancer US Market (USD Millions), (2013-2015)
• Figure 6: Nasopharyngeal Cancer US Market (USD Millions), (2016-2023)
• Figure 7: Nasopharyngeal Cancer Germany Market (USD Millions), (2013-2015)
• Figure 8: Nasopharyngeal Cancer Germany Market (USD Millions), (2016-2023)
• Figure 9: Nasopharyngeal Cancer United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Nasopharyngeal Cancer United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Nasopharyngeal Cancer France Market (USD Millions), (2013-2015)
• Figure 12: Nasopharyngeal Cancer France Market (USD Millions), (2016-2023)
• Figure 13: Nasopharyngeal Cancer Italy Market (USD Millions), (2013-2015)
• Figure 14: Nasopharyngeal Cancer Italy Market (USD Millions), (2016-2023)
• Figure 15: Nasopharyngeal Cancer Spain Market (USD Millions), (2013-2015)
• Figure 16: Nasopharyngeal Cancer Spain Market (USD Millions), (2016-2023)
• Figure 17: Nasopharyngeal Cancer Japan Market (USD Millions), (2013-2015)
• Figure 18: Nasopharyngeal Cancer Japan Market (USD Millions), (2015-2023)
• Figure 19: Nasopharyngeal Cancer ROW Market (USD Millions), (2013-2015)
• Figure 20: Nasopharyngeal Cancer ROW Market (USD Millions), (2016-2023)
【掲載企業】
• Ambrx Inc.
• AVEO Pharmaceuticals Inc.
• Biomics Biotechnologies Co. Ltd.
• Celgene Corporation
• Cell Medica Limited
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Merck & Co. Inc.
• Molecular Partners AG
• Ono Pharmaceutical Co. Ltd.
• Pharmacyclics Inc.
• Sapvax
• Shenzen SiBiono GeneTech Co. Ltd
• Theravectys SA
【レポートのキーワード】
上咽頭がん
【免責事項】
https://www.marketreport.jp/reports-disclaimer